Low-Dose Atropine Induces Changes in Ocular Biometrics in Myopic Children: Exploring Temporal Changes by Linear Mixed Models and Contribution to Treatment Effect by Mediation Analyses
This study aimed to investigate changes in non-cycloplegic ocular biometrics during the initial six months of treatment with a 0.1% atropine loading dose and 0.01% atropine compared with a placebo and analyze their contribution to the treatment effect on cycloplegic spherical equivalent (SE) progres...
Main Authors: | Anders Hvid-Hansen, Nina Jacobsen, Jesper Hjortdal, Flemming Møller, Brice Ozenne, Line Kessel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/4/1605 |
Similar Items
-
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
by: Anders Hvid-Hansen, et al.
Published: (2023-02-01) -
Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial
by: Niklas Cyril Hansen, et al.
Published: (2024-02-01) -
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
by: Niklas Cyril Hansen, et al.
Published: (2023-10-01) -
Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
by: Ming Wang, et al.
Published: (2023-01-01) -
Effectiveness of 0.01% atropine in anisomyopic children
by: Azfira Hussain, et al.
Published: (2023-01-01)